tradingkey.logo

Forte Biosciences Inc <FBRX.OQ> expected to post a loss of $1.11 a share - Earnings Preview

ReutersAug 8, 2025 11:57 AM
  • Forte Biosciences Inc FBRX.OQ FBRX.O is expected to show no change in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for Forte Biosciences Inc is for a loss of $1.11 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Forte Biosciences Inc is $57.00, about 81.9% above its last closing price of $10.30

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2025

-0.94

-0.95

-1.37

Missed

-44.2

Dec. 31 2025

-1.76

-3.27

-2.45

Beat

25.1

Sep. 30 2024

-7.15

-7.12

-4.54

Beat

36.3​

Jun. 30 2024

-4.16

-4.17

-6.75

Missed

-62

​​Mar. 31 2024

-4.13

-4.12

-4.00

Beat

3

Dec. 31 2023

-7.00

-4.65

Beat

33.6​

This summary was machine generated August 8 at 11:57 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI